Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Graham

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancerM C Graham, H I Scher, G B Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1995
Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancerA M Scott, H Macapinlac, J Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1993
Three-dimensional dosimetry for radioimmunotherapy treatment planningG Sgouros, S Chiu, K S Pentlow, et al.
Nuclear Medicine and Biology|July 1, 1994
Clinical applications of fusion imaging in oncologyA M Scott, H Macapinlac, J J Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1994
Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinomaA M Scott, H A Macapinlac, C R Divgi, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunotherapyS M Larson, C R Divgi, A Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
The Science of the Total Environment|October 6, 2005
The implications of integrated assessment and modelling studies for the future remediation of chromite ore processing residue disposal sitesJ G Farmer, E Paterson, R J F Bewley, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancerM C Graham, H I Scher, G B Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1995
Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancerA M Scott, H Macapinlac, J Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1993
Three-dimensional dosimetry for radioimmunotherapy treatment planningG Sgouros, S Chiu, K S Pentlow, et al.
Nuclear Medicine and Biology|July 1, 1994
Clinical applications of fusion imaging in oncologyA M Scott, H Macapinlac, J J Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1994
Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinomaA M Scott, H A Macapinlac, C R Divgi, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunotherapyS M Larson, C R Divgi, A Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
European Journal of Nuclear Medicine|May 1, 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in gliomaF Daghighian, K S Pentlow, S M Larson, et al.
The Science of the Total Environment|October 6, 2005
The implications of integrated assessment and modelling studies for the future remediation of chromite ore processing residue disposal sitesJ G Farmer, E Paterson, R J F Bewley, et al.
Pageof 6